Medicare Enrolled
Dr. Jose Melo, M.D.
Hematology & Oncology · Plantation, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Melo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melo
Dr. Jose Melo is a hematology & oncology specialist in Plantation, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Melo performed 104,859 Medicare services across 1,566 unique beneficiaries.
Between the years covered by Open Payments, Dr. Melo received a total of $34,078 from 84 pharmaceutical and/or device companies across 1910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in FL
$34,078 industry payments
Medicare Practice Summary
Medicare Utilization ↗104,859
Medicare services
Top 7% in FL for hematology & oncology
1,566
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,519 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
47,500 | $2 | $21 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
42,000 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 7,200 | $18 | $71 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,425 | $8 | $35 |
| Iron infusion (Monoferric) | 1,400 | $17 | $72 |
| Anti-nausea injection (ondansetron/Zofran) | 1,272 | $0 | $4 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,130 | $6 | $30 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
808 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
659 | $68 | $148 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
358 | $11 | $93 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
168 | $66 | $158 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
156 | $23 | $152 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
153 | $49 | $304 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
146 | $105 | $686 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
110 | $145 | $412 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $44 | $120 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
88 | $1 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
73 | $12 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $133 | $343 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $90 | $224 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $100 | $241 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.8% high complexity
55.7% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,078
Total received (2018-2024)
Avg $4,868/year across 7 years
Top 18% in FL for hematology & oncology
84
Companies
1,910
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,123 (85.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,080 (9.0%)
Other
Charitable contributions, space rental, and other categories
$1,875 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,589
2023
$5,605
2022
$5,168
2021
$5,400
2020
$3,903
2019
$4,414
2018
$4,000
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,148
Novartis Pharmaceuticals Corporation
$3,117
Janssen Biotech, Inc.
$2,255
Genentech USA, Inc.
$2,102
PFIZER INC.
$2,080
E.R. Squibb & Sons, L.L.C.
$1,604
Astellas Pharma US Inc
$1,385
Incyte Corporation
$1,303
Celgene Corporation
$1,129
Seagen Inc.
$1,106
Amgen Inc.
$1,011
Merck Sharp & Dohme LLC
$921
Exelixis Inc.
$845
Lilly USA, LLC
$823
Takeda Pharmaceuticals U.S.A., Inc.
$798
GENZYME CORPORATION
$718
Eisai Inc.
$713
Merck Sharp & Dohme Corporation
$558
Rigel Pharmaceuticals, Inc.
$458
Seattle Genetics, Inc.
$366
ABBVIE INC.
$355
Daiichi Sankyo Inc.
$351
ARRAY BIOPHARMA INC
$280
GlaxoSmithKline, LLC.
$276
EISAI INC.
$272
Deciphera Pharmaceuticals Inc.
$250
Ipsen Biopharmaceuticals, Inc
$245
Foundation Medicine, Inc.
$243
Bayer HealthCare Pharmaceuticals Inc.
$234
Pharmacosmos Therapeutics Inc.
$219
Alexion Pharmaceuticals, Inc.
$212
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
AVEO Pharmaceuticals, Inc.
$203
PUMA BIOTECHNOLOGY, INC.
$199
Mirati Therapeutics, Inc.
$199
JAZZ PHARMACEUTICALS INC.
$196
Regeneron Healthcare Solutions, Inc.
$193
BeiGene USA, Inc.
$190
Pharmacyclics LLC, An AbbVie Company
$190
Puma Biotechnology, Inc.
$180
Karyopharm Therapeutics Inc.
$180
AbbVie, Inc.
$173
NOVARTIS PHARMACEUTICALS CORPORATION
$167
AbbVie Inc.
$146
Dova Pharmaceuticals
$144
TAIHO ONCOLOGY, INC.
$141
Adaptive Biotechnologies Corporation
$141
EMD Serono, Inc.
$135
Janssen Pharmaceuticals, Inc
$105
Bayer Healthcare Pharmaceuticals Inc.
$105
SEAGEN INC.
$100
SANOFI-AVENTIS U.S. LLC
$100
Agios Pharmaceuticals, Inc.
$72
Sirtex Medical Inc
$65
Kyowa Kirin, Inc.
$61
Teva Pharmaceuticals USA, Inc.
$60
Myovant Sciences Inc.
$59
MEDIVATION FIELD SOLUTIONS LLC
$59
Amneal Pharmaceuticals LLC
$54
SHIELD THERAPEUTICS INC
$54
Blueprint Medicines Corporation
$54
SERVIER PHARMACEUTICALS LLC
$54
Taiho Oncology, Inc.
$53
Jazz Pharmaceuticals Inc.
$52
Gilead Sciences, Inc.
$52
TG Therapeutics, Inc.
$48
Sobi, Inc
$47
Acceleron Pharma, Inc.
$45
Sumitomo Pharma America, Inc.
$45
MorphoSys, US Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$41
Epizyme, Inc.,
$37
Alnylam Pharmaceuticals Inc.
$27
Sun Pharmaceutical Industries Inc.
$25
Sandoz Inc.
$24
Secura Bio, Inc.
$24
Servier Pharmaceuticals LLC
$22
ADC Therapeutics America, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$20
TG THERAPEUTICS, INC.
$20
Tolmar, Inc.
$19
G1 Therapeutics, Inc.
$18
Advanced Accelerator Applications
$18
SOBI, INC
$15
Top 3 companies account for 25.0% of total payments
Associated products mentioned in payments ›
ABILIFY · ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BENDEKA · BEVESPI AEROSPHERE · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · INVOKANA · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Non-Covered Product · Nplate · Nubeqa · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rozlytrek · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VYNDAQEL · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZARXIO · ZEJULA · ZEPZELCA · ZIEXTENZO · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $32 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
116
Per 100K population
6.0
County median income
$74,534
Nearest hospital
WESTSIDE REGIONAL MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Melo is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Melo experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Melo performed 47,500 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melo receive payments from pharmaceutical companies?
Yes. Dr. Melo received a total of $34,078 from 84 companies across 1,910 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melo's costs compare to other hematology & oncology specialists in Plantation?
Dr. Melo's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Plantation
Browse hematology & oncology specialists in Plantation ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology